Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital

Medical Mycology

Volumn 46, Issue 3, 2008, Pages 225-230

  Torres Narbona, M ^a   Guinea, J ^a,b   Martinez Alarcon, J ^a   Munoz, P ^a,b   Pelaez, T ^a,b   Bouza, E ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Isolation; Mucor; Mucormycosis; Workload; Zygomycosis

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BUDESONIDE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; POSACONAZOLE; PREDNISONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FUNGAL COLONIZATION; FUNGAL CONTAMINATION; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; GENERAL HOSPITAL; GRAFT REJECTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MUCORMYCOSIS; NEUTROPENIA; NONHODGKIN LYMPHOMA; NONHUMAN; RETROSPECTIVE STUDY; WORKLOAD; ZYGOMYCETES; EVALUATION; HOSPITAL LABORATORY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; TEACHING HOSPITAL; TIME; TREATMENT OUTCOME;

FUNGI; MUCOR; ZYGOMYCETES;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALS, TEACHING; HUMANS; LABORATORIES, HOSPITAL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WORKLOAD; ZYGOMYCOSIS; ZYGOMYCOTA;

EID: 47249087794     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780701796973     Document Type: Article

References (42)

1. Kontoyiannis, DP, Wessel, VC, Bodey, GP and Rolston, KV. (2000) Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis, 30, pp. 851-856.
2. Nussbaum, ES and Hall, WA. (1994) Rhinocerebral mucormycosis: Changing patterns of disease. Surg Neurol, 41, pp. 152-156.
3. Rickerts, V., Bohme, A. and Just-Nubling, G. (2002) [Risk factor for invasive zygomycosis in patients with hematologic malignancies]. Mycoses, 45, pp. 27-30.
4. Kauffman, CA. (2004) Zygomycosis: Reemergence of an old pathogen. Clin Infect Dis, 39, pp. 588-590.
5. Gartenberg, G., Bottone, EJ, Keusch, GT and Weitzman, I. (1978) Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: Epidemiology, mycology and treatment. N Engl J Med, 299, pp. 1115-1118.
6. Petrikkos, G., Skiada, A. and Sambatakou, H. (2003) Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis, 22, pp. 753-756.
7. Baraia, J., Munoz, P., de Quiros, JC Bernaldo and Bouza, E. (1995) Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter. Eur J Clin Microbiol Infect Dis, 14, pp. 813-815.
8. Rees, JR, Pinner, RW, Hajjeh, RA, Brandt, ME and Reingold, AL. (1998) The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: Results of population-based laboratory active surveillance. Clin Infect Dis, 27, pp. 1138-1147.
9. Hotchi, M., Okada, M. and Nasu, T. (1980) Present state of fungal infections in autopsy cases in Japan. Am J Clin Pathol, 74, pp. 410-416.
10. Tietz, HJ, Martin, H. and Koch, S. (2001) Incidence of endomycoses in autopsy material. Mycoses, 44, pp. 450-454.
11. Yamazaki, T., Kume, H., Murase, S., Yamashita, E. and Arisawa, M. (1999) Epidemiology of visceral mycoses: Analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol, 37, pp. 1732-1738.
12. Maertens, J., Demuynck, H. and Verbeken, EK (1999) Mucormycosis in allogeneic bone marrow transplant recipients: Report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant, 24, pp. 307-312.
13. Verweij, PE, Voss, A., Donnelly, JP, de Pauw, BE and Meis, JF. (1997) Wooden sticks as the source of a pseudoepidemic of infection with Rhizopus microsporus var. rhizopodiformis among immunocompromised patients. J Clin Microbiol, 35, pp. 2422-2423.
14. Mitchell, SJ, Gray, J., Morgan, ME, Hocking, MD and Durbin, GM. (1996) Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet, 348, pp. 441-443.
15. Marty, FM, Cosimi, LA and Baden, LR. (2004) Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med, 350, pp. 950-952.
16. Marr, KA, Carter, RA, Crippa, F., Wald, A. and Corey, L. (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis, 34, pp. 909-917.
17. Siwek, GT, Dodgson, KJ and de Magalhaes-Silverman, M. (2004) Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis, 39, pp. 584-587.
18. Vigouroux, S., Morin, O. and Moreau, P. (2005) Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: Attention required. Clin Infect Dis, 40, p. e35.
19. Chamilos, G., Marom, EM, Lewis, RE, Lionakis, MS and Kontoyiannis, DP. (2005) Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis, 41, pp. 60-66.
20. Ide, L., Buysschaert, I. and Demuynck, H. (2004) Zygomycosis in neutropenic patients with past Aspergillus infection: A role for posaconazole?. Clin Microbiol Infect, 10, pp. 862-863.
21. Imhof, A., Balajee, SA, Fredricks, DN, Englund, JA and Marr, KA. (2004) Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis, 39, pp. 743-746.
22. Jacobs, P., Wood, L., Toit, A Du and Esterhuizen, K. (2003) Eradication of invasive mucormycosis-effectiveness of the Echinocandin FK463. Hematology, 8, pp. 119-123.
23. Wingard, JR. (2005) The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr Opin Oncol, 17, pp. 89-92.
24. Maertens, J. (2007) Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies. Eur J Haematol, 78, p. 546.
25. Trifilio, S., Singhal, S. and Williams, S. (2007) Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant, 40, pp. 451-456.
26. Kontoyiannis, DP, Lionakis, MS, Lewis, RE, Walsh, TJ and Raad, II (2004) Zygomycosis in the era of voriconazole in a cancer center: A matched case-control observational study of 27 recent patients. 44rd Annual Interscience Conference on Antimicrobial and Chemotherapy, Washington, DC
27. Kobayashi, K., Kami, M. and Murashige, N. (2004) Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis. Haematologica, 89, p. ECR42.
28. Ribes, JA, Vanover-Sams, CL and Baker, DJ. (2000) Zygomycetes in human disease. Clin Microbiol Rev, 13, pp. 236-301.
29. Connolly Jr, JE, McAdams, HP, Erasmus, JJ and Rosado-de-Christenson, ML. (1999) Opportunistic fungal pneumonia. J Thorac Imaging, 14, pp. 51-62.
30. LeMaile-Williams, M., Burwell, LA and Salisbury, D. (2006) Outbreak of cutaneous Rhizopus arrhizus infection associated with karaya ostomy bags. Clin Infect Dis, 43, p. e83.
31. Anuradha, K., Lakshmi, V., Umabala, P. and Rao, MN. (2006) Pulmonary zygomycosis in a diabetic patient. Indian J Med Microbiol, 24, pp. 222-224.
32. Schalk, E., Mohren, M. and Jentsch-Ullrich, K. (2006) Zygomycoses in patients with acute leukaemia. Ann Hematol, 85, pp. 327-332.
33. Ascioglu, S., Rex, JH and de Pauw, B. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis, 34, pp. 7-14.
34. Richardson, MD, Koulkila-Kahkola, P. and Shankland, GS. (2003) Rhizomycor, Absidia, and other agents of systemic and subcutaneous zygomycoses. Manual of Clinical Microbiology, pp. 761-780. ASM Press, Washington, DC
35. Torres-Narbona, M., Guinea, J. and Martinez-Alarcon, J. (2007) Impact of zygomycosis on microbiology workload: A survey study in Spain. J Clin Microbiol, 45, pp. 2051-2053.
36. Mori, T., Egashira, M. and Kawamata, N. (2003) Zygomycosis: Two case reports and review of reported cases in the literature in Japan. Nippon Ishinkin Gakkai Zasshi, 44, pp. 163-179.
37. Guevara, N., Roy, D. and Dutruc-Rosset, C. (2004) Mucormycosis - early diagnosis and treatment. Rev Laryngol Otol Rhinol (Bord), 125, pp. 127-131.
38. Guinea, J., Pelaez, T., Munoz, P. and Bouza, E. (2005) How frequent are agents responsible for mucormycosis in outdoor air?. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC
39. Kontoyiannis, DP, Lionakis, MS and Lewis, RE (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases. J Infect Dis, 191, pp. 1350-1360.
40. Trifilio, SM, Bennett, CL and Yarnold, PR (2007) Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant, 39, pp. 425-429.
41. Bethge, WA, Schmalzing, M. and Stuhler, G. (2005) Mucormycoses in patients with hematologic malignancies: An emerging fungal infection. Haematologica, 90, p. ECR22.
42. Glockner, A., Vehreschild, JJ and Cornely, OA. (2007) Zygomycosis - current epidemiological aspects. Mycoses, 50, pp. 50-55.